Date published: 2026-5-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

PAPA NONOate (CAS 146672-58-4)

5.0(1)
Write a reviewAsk a question

See product citations (8)

Alternate Names:
PAPA/NO; NOC-15; (Z)-1-[N-(3-Ammoniopropyl)-N-(n-propyl)amino]diazen-1-ium-1,2-diolate
Application:
PAPA NONOate is an NO donor which suppresses the caspase apoptotic cascade
CAS Number:
146672-58-4
Purity:
>97%
Molecular Weight:
176.22
Molecular Formula:
C6H16N4O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

PAPA NONOate is a diazeniumdiolate small molecule NO donor with a reported NO release half-life of 77 min (22-25degC). NO release from PAPA NONOate has demonstrated regulation of caspase-3 activity and suppression of the caspase apoptotic cascade via inhibition of S-nitrosylation of the Cys-163 residue on caspase-3. In NO-vacant NT2N cells, NO release from PAPA NONOate produced cell death through apoptotic signaling, as contrasted with the necrotic injury produced by peroxynitrite exposure. NO release from PAPA NONOate is shown to increase cGMP in a model of ischemic lung injury, suggesting that the protective effects of NO against ischemic injury are cGMP-mediated. PAPA NONOate also demonstrated inhibition of protein synthesis in A375 melanoma cells through release of NO, inhibiting thymidine incorporation by 50% (44 muM) and producing a cytostatic effect. PAPA NONOate exhibits anti-inflammatory, antioxidant, and neuroprotective properties. By inhibiting certain enzymes like cyclooxygenase-2 (COX-2), which contributes to inflammation, and activating receptors such as cannabinoid receptors involved in pain regulation, inflammation, and other physiological processes, Papa Nonoate exerts its effects.


PAPA NONOate (CAS 146672-58-4) References

  1. [Fibrinolysis in the oral cavity].  |  Riobóo, R. 1976. Rev Stomatol Chir Maxillofac. 77: 287-8. PMID: 1066732
  2. Two distinct mechanisms of nitric oxide-mediated neuronal cell death show thiol dependency.  |  Gow, AJ., et al. 2000. Am J Physiol Cell Physiol. 278: C1099-107. PMID: 10837337
  3. Effect of time and vascular pressure on permeability and cyclic nucleotides in ischemic lungs.  |  Pearse, DB. and Becker, PM. 2000. Am J Physiol Heart Circ Physiol. 279: H2077-84. PMID: 11045940
  4. Nitric oxide inhibits cAMP-dependent CFTR trafficking in intestinal epithelial cells.  |  Skinn, AC. and MacNaughton, WK. 2005. Am J Physiol Gastrointest Liver Physiol. 289: G739-44. PMID: 15994425
  5. Synergistic antiglioma action of hyperthermia and nitric oxide.  |  Janjetovic, K., et al. 2008. Eur J Pharmacol. 583: 1-10. PMID: 18262519
  6. Biphasic effect of nitric oxide on the cardiac voltage-dependent anion channel.  |  Cheng, Q., et al. 2011. FEBS Lett. 585: 328-34. PMID: 21156174
  7. Characterization of diazeniumdiolate nitric oxide donors (NONOates) by electrospray ionization mass spectrometry.  |  Rivera-Tirado, E., et al. 2011. Rapid Commun Mass Spectrom. 25: 3581-6. PMID: 22095507
  8. Mechanistic studies of oxidative decomposition of Angeli's salt and PAPA NONOate.  |  Bobko, AA. and Khramtsov, VV. 2014. Nitric Oxide. 40: 92-8. PMID: 24947085
  9. Modulation of cellular bioenergetics by CO-releasing molecules and NO-donors inhibits the interaction of cancer cells with human lung microvascular endothelial cells.  |  Stojak, M., et al. 2018. Pharmacol Res. 136: 160-171. PMID: 30196104
  10. Nitric oxide-dependent biodegradation of graphene oxide reduces inflammation in the gastrointestinal tract.  |  Peng, G., et al. 2020. Nanoscale. 12: 16730-16737. PMID: 32785315
  11. Induction of Activity-Dependent Plasticity at Auditory Nerve Synapses.  |  Wong, NF. and Xu-Friedman, MA. 2022. J Neurosci. 42: 6211-6220. PMID: 35790402
  12. Role of Nitric Oxide-Derived Metabolites in Reactions of Methylglyoxal with Lysine and Lysine-Rich Protein Leghemoglobin.  |  Shumaev, KB., et al. 2022. Int J Mol Sci. 24: PMID: 36613614
  13. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators.  |  Morley, D. and Keefer, LK. 1993. J Cardiovasc Pharmacol. 22 Suppl 7: S3-9. PMID: 7504766
  14. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release.  |  Maragos, CM., et al. 1993. Cancer Res. 53: 564-8. PMID: 8425188
  15. 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.  |  Keefer, LK., et al. 1996. Methods Enzymol. 268: 281-93. PMID: 8782594

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PAPA NONOate, 5 mg

sc-202272
5 mg
$38.00

PAPA NONOate, 25 mg

sc-202272A
25 mg
$111.00